Skip to main content
IC
Bausch + Lomb Corporation (TSX:BLCO)
Canada flag Canada · Delayed Price · Currency is CAD
16.59
+0.05 (0.30%)
May 13, 2025, 10:25 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Vision Care
Log In
Log In
Log In
Log In
Vision Care Growth
Log In
Log In
Log In
Log In
Surgical
Log In
Log In
Log In
Log In
Surgical Growth
Log In
Log In
Log In
Log In
Ophthalmic Pharmaceuticals
Log In
Log In
Log In
Log In
Ophthalmic Pharmaceuticals Growth
Log In
Log In
Log In
Log In
Pharmaceuticals
Log In
Log In
Log In
Log In
Pharmaceuticals Growth
Log In
Log In
Log In
Log In
Devices
Log In
Log In
Log In
Log In
Devices Growth
Log In
Log In
Log In
Log In
OTC
Log In
Log In
Log In
Log In
OTC Growth
Log In
Log In
Log In
Log In
Branded and Other Generics
Log In
Log In
Log In
Log In
Branded and Other Generics Growth
Log In
Log In
Log In
Log In
Total Product
Log In
Log In
Log In
Log In
Total Product Growth
Log In
Log In
Log In
Log In
Other Product
Log In
Log In
Log In
Log In
Other Product Growth
Log In
Log In
Log In
Log In

Capex by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Vision Care Capital Expenditures
Log In
Log In
Log In
Log In
Vision Care Capital Expenditures Growth
Log In
Log In
Log In
Log In
Surgical Segment Expenditures
Log In
Log In
Log In
Log In
Surgical Segment Expenditures Growth
Log In
Log In
Log In
Log In
Ophthalmic Pharmaceuticals Capital Expenditures
Log In
Log In
Log In
Log In
Ophthalmic Pharmaceuticals Capital Expenditures Growth
Log In
Log In
Log In
Log In
Corporate Capital Expenditures
Log In
Log In
Log In
Log In
Corporate Capital Expenditures Growth
Log In
Log In
Log In
Log In

EBIT by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Vision Care Segment Profit
Log In
Log In
Log In
Log In
Vision Care Segment Profit Growth
Log In
Log In
Log In
Log In
Surgical Segment Profit
Log In
Log In
Log In
Log In
Surgical Segment Profit Growth
Log In
Log In
Log In
Log In
Ophthalmic Pharmaceuticals Segment Profit
Log In
Log In
Log In
Log In
Ophthalmic Pharmaceuticals Segment Profit Growth
Log In
Log In
Log In
Log In
Corporate Segment Profit
Log In
Log In
Log In
Log In
Corporate Segment Profit Growth
Log In
Log In
Log In
Log In
Amortization of Intangible Assets
Log In
Log In
Log In
Log In
Amortization of Intangible Assets Growth
Log In
Log In
Log In
Log In
Net Other Expense
Log In
Log In
Log In
Log In
Net Other Expense Growth
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
U.S. and Puerto Rico
Log In
Log In
Log In
Log In
U.S. and Puerto Rico Growth
Log In
Log In
Log In
Log In
Total International
Log In
Log In
Log In
Log In
Total International Growth
Log In
Log In
Log In
Log In

Other

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Vision Care Revenue Organic Change
Log In
Log In
Log In
Log In
Vision Care Revenue Organic Change Growth
Log In
Log In
Log In
Log In
Ophthalmic Pharmaceuticals Revenue Organic Change
Log In
Log In
Log In
Log In
Ophthalmic Pharmaceuticals Revenue Organic Change Growth
Log In
Log In
Log In
Log In
Surgical Revenue Organic Change
Log In
Log In
Log In
Log In
Surgical Revenue Organic Change Growth
Log In
Log In
Log In
Log In
Total Revenue Organic Change
Log In
Log In
Log In
Log In
Total Revenue Organic Change Growth
Log In
Log In
Log In
Log In
Vision Care Revenue Change in Constant Currency
Log In
Log In
Log In
Log In
Vision Care Revenue Change in Constant Currency Growth
Log In
Log In
Log In
Log In
Surgical Revenue Change in Constant Currency
Log In
Log In
Log In
Log In
Surgical Revenue Change in Constant Currency Growth
Log In
Log In
Log In
Log In
Total Revenue Change in Constant Currency
Log In
Log In
Log In
Log In
Total Revenue Change in Constant Currency Growth
Log In
Log In
Log In
Log In
Ophthalmic Pharmaceuticals Revenue Change in Constant Currency
Log In
Log In
Log In
Log In
Ophthalmic Pharmaceuticals Revenue Change in Constant Currency Growth
Log In
Log In
Log In
Log In